Top Markets
Coin of the day
GenSight Biologics S.A. GenSight Biologics S.A.

GenSight Biologics S.A.

SIGHT
Clasificación en acciones #29513
GenSight Biologics S.A. is a clinical-stage biotechnology firm focused on... GenSight Biologics S.A. is a clinical-stage biotechnology firm focused on identifying, advancing, and commercializing medical interventions for severe mitochondrial and neurodegenerative conditions affecting both the eyes and the central nervous system. Their therapeutic development leverages cutting-edge gene therapy platforms, specifically those involving mitochondrial targeting sequences and optogenetics. The company's leading drug candidate, LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, is currently undergoing Phase III clinical evaluation for treating Leber hereditary optic neuropathy (LHON) caused by a specific ND4 gene mutation. Another significant program, GS030, is engaged in Phase I/II clinical trials for retinitis pigmentosa and is also in the preclinical phase for dry age-related macular degeneration. Furthermore, GenSight Biologics is developing additional preclinical-stage programs aimed at various ophthalmic and neurodegenerative disorders. The company was founded in 2012 and maintains its headquarters in Paris, France.
Precio por acción
$0.12857922
Capitalización bursátil
$20.96M
Cambio (1 día)
3.63%
Cambio (1 año)
-36.21%
País
FR
Comercio GenSight Biologics S.A. (SIGHT)

Categoría

Historial del precio de la acción de GenSight Biologics S.A. (SIGHT)
Precio más alto de cierre: $0.11 el 2026-08-01

Precio más bajo de cierre: $8.93 el 2016-07-01
Historial del precio de la acción de GenSight Biologics S.A. desde 2016 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.84%
2025 -61.96%
2024 -40.41%
2023 -85.79%
2022 -40.62%
2021 -23.84%
2020 252.34%
2019 -43.91%
2018 -36.71%
2017 -20.44%
2016 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$534.00 36.66%
US
$1.01K 54.27%
NL
$117.42 -19.34%
AU
$752.50 8.47%
CH
$1.07K -5.58%
KR